Liraglutide compromises pancreatic beta cell function in a humanized mouse model
On the web-site of Karolinska Institutet, there is a recent post regarding a new publication of high impact:
“Long-term use of liraglutide, a substance that helps to lower blood sugar levels in patients with type 2 diabetes, can have a deteriorating effect on insulin-producing beta cells, leading to an increase in blood sugar levels. This according to a study on mice implanted with human insulin-producing cells conducted by a team of scientists from Karolinska Institutet, and the University of Miami, USA. The researchers flag the possible consequences of this popular form of therapy in Cell Metabolism.”
Read more: